バスキュラーアクセスデバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界のバスキュラーアクセスデバイスの市場規模は、2023年に45億9,000万米ドル、2030年までに67億5,000万米ドルに達し、2024年～2030年の予測期間にCAGRで6.64％の成長が見込まれます。バスキュラーアクセスデバイスの需要は、主にこれらのデバイスの使用を必要とするがん、腎不全、心臓病などの慢性疾患の有病率の増加によって促進されています。その他、化学療法の増加、生活習慣病、小児患者における罹患率の上昇などの要因も、市場の成長を後押しする可能性があります。

バスキュラーアクセスデバイスの市場力学

世界中での慢性疾患や感染症の流行が、バスキュラーアクセスデバイス市場の成長を加速させる見込みです。例えばGlobal Cancer Observatory data（2020）によると、2020年に世界で約57万3,000件の膀胱がんが報告されています。同資料によると、2040年までにこの数は91万3,000人に達すると推定されています。

上記の資料によれば、2020年に世界中で新たに43万1,000件の腎臓と腎盂のがんが診断され、2040年までに60万6,000件に増加すると予測されています。

Globocan（2020）によると、2020年に世界で141万人の前立腺がん患者が新たに登録されました。同資料によると、2040年までに約224万人の前立腺がん患者が新たに記録される予定です。

International Society of Nephrologyが発表した最新のデータによると、2022年に全世界で8億5,000万人が何らかの腎臓病を患っています。さらに、世界全体で530万人から1,050万人が透析や移植を必要としています。

しかし、さまざまなバスキュラーアクセスデバイスに関連する合併症や高いコストが、バスキュラーデバイス市場全体の成長を抑制する可能性があります。

バスキュラーアクセスデバイス市場のセグメント分析

バスキュラーアクセスデバイス市場のデバイスタイプセグメントでは、末梢留置型中心静脈カテーテル（PICC）カテゴリが最大のシェアを占めると予測されています。これはPICCに関連する利点によるものです。

PICCは一般に、がんや感染症などのさまざまな疾患を患う患者の腕の静脈から挿入し、薬剤や液体の栄養を投与するために使用されます。

PICCは、輸液や採血のための長期的なアクセスを可能にします。これにより、医師は心臓に近い太い中心静脈にアクセスして、効果的な薬剤投与を行うことができます。

PICCは痛みが少なく、頻繁に針を刺すことを避けることができます。また、腕に存在する細い静脈への刺激のリスクも軽減されます。

PICCには複数のルーメンがあることも利点です。複数のソースから供給されるチューブとキャップがルーメンを構成します。その結果、患者は一度に複数の薬剤を受け取ることができます。例えば、輸液と化学療法を同時に受けることができます。

したがって、末梢挿入型中心静脈カテーテル（PICC）に関連する利点を考慮すると、この製品カテゴリは最終的に大きな収益シェアを生み出し、予測期間中のバスキュラーアクセスデバイス市場全体の成長に寄与すると予測されます。

北米がバスキュラーアクセスデバイス市場全体を独占する見込み

北米は予測期間にバスキュラーアクセスデバイス市場全体を独占する見込みです。この優位性は、バスキュラーアクセスデバイスにおける先進技術への需要の高まり、慢性疾患や感染症に苦しむ患者の治療ニーズの高まり、その他の地域における製品開発活動の活発化などによるものです。

American Cancer Societyが引用した統計によると、2023年に米国で新たに約8万2,290人の膀胱がん患者（男性約6万2,420人、女性約1万9,870人）が報告されます。

当レポートでは、世界のバスキュラーアクセスデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 バスキュラーアクセスデバイス市場レポートのイントロダクション

第2章 バスキュラーアクセスデバイス市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 バスキュラーアクセスデバイス市場の主な要因の分析

• バスキュラーアクセスデバイス市場の促進要因
  • 慢性疾患の流行
  • 化学療法の増加
  • 小児患者における生活習慣病の発生の増加
• バスキュラーアクセスデバイス市場の抑制要因と課題
  • これらのデバイスの不適切な配置
  • これらのデバイスの高いコスト
• バスキュラーアクセスデバイス市場の機会
  • 腎臓病患者における適切な水分補給への関心の高まり
  • 生物活性材料でコーティングされたデバイスの入手可能性の高まり

第5章 バスキュラーアクセスデバイスのポーターのファイブフォース分析

第6章 バスキュラーアクセスデバイス市場のレイアウト

• デバイスタイプ別
  • 中心静脈アクセスデバイス
  • 末梢静脈アクセスデバイス
• 挿入経路別
  • 静脈
  • 皮下
• エンドユーザー別
  • 病院
  • 外来手術センター
  • その他
• 地域別
  • 北米のバスキュラーアクセスデバイス市場（2021年～2030年）
  • 欧州のバスキュラーアクセスデバイス市場（2021年～2030年）
  • アジア太平洋のバスキュラーアクセスデバイス市場（2021年～2030年）
  • その他の地域のバスキュラーアクセスデバイス市場（2021年～2030年）

第7章 バスキュラーアクセスデバイスの企業と製品のプロファイル

• Cook Medical Inc.
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic PLC
• B Braun Melsungen AG
• Nipro Medical Corporation
• Smiths Group PLC
• C. R. Bard, Inc.
• Edwards Lifesciences Corporation
• AngioDynamics
• Terumo Medical Corporation
• Amecath Medical Technologies
• Prodimed
• B Braun Melsungen AG
• Zoll Medical Corporation

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Vascular Access Devices Market in Global (2021-2030)
• Table 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
• Table 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
• Table 5: Vascular Access Devices Market in Global by End-User (2021-2030)
• Table 6: Vascular Access Devices Market in Global by Geography (2021-2030)
• Table 7: Vascular Access Devices Market in North America (2021-2030)
• Table 8: Vascular Access Devices Market in the US (2021-2030)
• Table 9: Vascular Access Devices Market in Canada (2021-2030)
• Table 10: Vascular Access Devices Market in Mexico (2021-2030)
• Table 11: Vascular Access Devices Market in Europe (2021-2030)
• Table 12: Vascular Access Devices Market in France (2021-2030)
• Table 13: Vascular Access Devices Market in Germany (2021-2030)
• Table 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
• Table 15: Vascular Access Devices Market in Italy (2021-2030)
• Table 16: Vascular Access Devices Market in Spain (2021-2030)
• Table 17: Vascular Access Devices Market in Rest of Europe (2021-2030)
• Table 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
• Table 19: Vascular Access Devices Market in China (2021-2030)
• Table 20: Vascular Access Devices Market in Japan (2021-2030)
• Table 21: Vascular Access Devices Market in India (2021-2030)
• Table 22: Vascular Access Devices Market in Australia (2021-2030)
• Table 23: Vascular Access Devices Market in South Korea (2021-2030)
• Table 24: Vascular Access Devices Market in Rest of Asia Pacific (2021-2030)
• Table 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
• Table 26: Vascular Access Devices Market in the Middle East (2021-2030)
• Table 27: Vascular Access Devices Market in Africa (2021-2030)
• Table 28: Vascular Access Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Vascular Access Devices Market in Global (2021-2030)
• Figure 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
• Figure 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
• Figure 5: Vascular Access Devices Market in Global by End-User (2021-2030)
• Figure 6: Vascular Access Devices Market in Global by Geography (2021-2030)
• Figure 7: Vascular Access Devices Market in North America (2021-2030)
• Figure 8: Vascular Access Devices Market in the US (2021-2030)
• Figure 9: Vascular Access Devices Market in Canada (2021-2030)
• Figure 10: Vascular Access Devices Market in Mexico (2021-2030)
• Figure 11: Vascular Access Devices Market in Europe (2021-2030)
• Figure 12: Vascular Access Devices Market in France (2021-2030)
• Figure 13: Vascular Access Devices Market in Germany (2021-2030)
• Figure 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
• Figure 15: Vascular Access Devices Market in Italy (2021-2030)
• Figure 16: Vascular Access Devices Market in Spain (2021-2030)
• Figure 17: Vascular Access Devices Market in the Rest of Europe (2021-2030)
• Figure 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
• Figure 19: Vascular Access Devices Market in China (2021-2030)
• Figure 20: Vascular Access Devices Market in Japan (2021-2030)
• Figure 21: Vascular Access Devices Market in India (2021-2030)
• Figure 22: Vascular Access Devices Market in Australia (2021-2030)
• Figure 23: Vascular Access Devices Market in South Korea (2021-2030)
• Figure 24: Vascular Access Devices Market in the Rest of Asia Pacific (2021-2030)
• Figure 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
• Figure 26: Vascular Access Devices Market in the Middle East (2021-2030)
• Figure 27: Vascular Access Devices Market in Africa (2021-2030)
• Figure 28: Vascular Access Devices in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Market Opportunities
• Figure 32: PORTER'S Five Force Analysis

Vascular Access Device Market By Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheters (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (Short) Devices, and Others]), Route Of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of infectious diseases and rising technological advancements in the product portfolio

The global vascular access device market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030. The demand for vascular access device is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients may drive the growth of the market.

Vascular Access Device Market Dynamics:

The increasing prevalence of chronic and infectious diseases globally is going to accelerate the growth of the vascular access device market. For instance, according to Global Cancer Observatory data 2020, globally about 573 thousand cases of bladder cancer were reported in 2020. As per the same source, it has been estimated that by 2040, the number is likely to reach up to 913 thousand.

As per the above-mentioned source, worldwide around 431 thousand new cancer cases of kidney and renal pelvis were diagnosed in 2020 and the cases are expected to increase to 606 thousand by 2040.

The Globocan 2020 says that, worldwide 1.41 million new cases of prostate cancer were registered in 2020. As per the same source, around 2.24 million new cases of prostate cancer are going to be recorded in 2040.

The latest data published by the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022. The source further mentioned that between 5.3 and 10.5 million people needed dialysis or transplantation globally.

However, complications and high costs associated with different vascular access devices may restrict the growth of the overall vascular devices market.

Vascular Access Device Market Segment Analysis:

Vascular Access Device by Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheter (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (short) Devices, and Others]), Route of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the vascular access device market, the peripherally inserted central catheters (PICC) category under the central vascular access device is expected to hold the largest share. This is owing to the advantages that are associated with PICC.

PICCS are generally used to give medications or liquid nutrition upon insertion through a vein in the arm of patients suffering from various diseases including cancer, infectious diseases, and others.

PICCs allow for long-term access to inject fluids or draw blood. These allow doctors to access the large central veins near the heart for effective administration of medications.

PICCs are associated with less pain and help avoid frequent needle sticks. They also reduce the risk of irritation to the smaller veins present in the arms.

The fact that PICCs can have several lumens is another advantage. The tubing and caps that feed from multiple sources make up a lumen. As a result, a patient may receive multiple medications at once. For instance, they might have fluids and chemotherapy at the same time.

Therefore, considering the advantages associated with peripherally inserted central catheters (PICCs), this product category is expected to generate significant revenue share eventually contributing to the overall growth of the vascular access device market in the forecast period.

North America is expected to dominate the overall Vascular Access Device Market:

North America is expected to dominate the overall vascular access device market during the forecast period. This domination is due to the growing demand for advanced technologies in vascular access devices, the rising need to treat patients suffering from chronic and infectious diseases, and increasing product development activities in the region among others.

The statistics cited by the American Cancer Society, in 2023, stated that about 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women will be reported in the US.

According to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF), a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States, every year on average.

In addition, people suffering from cystic fibrosis need intravenous (IV) antibiotic treatments for more than just a few days, such as during an exacerbation, which could potentially raise the demand for vascular access devices such as PICCs and others.

Also, a rise in hospital enrolment due to a surge in infectious diseases that require the administration of medications in the veins will contribute to the vascular access devices market growth.

For instance, according to CDC 2022, it was estimated that around 1,189,700 people aged 13 and above had HIV in the US in 2019.

Moreover, continuous regulatory approvals in the region are likely to boost the demand for vascular access devices in the coming years. For example, in March 2020, the Biowy PICC-S kit received 510(k) clearance from the US FDA.

Therefore, along with the presence of a large patient pool in the country, the increasing focus of key manufacturers on launching new products in the market is expected to bolster the growth of the vascular access device market in the United States during the forecast period.

Vascular Access Device Market Key Players:

Some of the key market players operating in the vascular access device market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

Recent Developmental Activities in the Vascular Access Device Market:

In August 2021, PuraCath Medical(TM), a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly(TM) Needleless Connector from the US Food and Drug Administration (FDA). The Firefly(TM) Needleless Connector is a sterile single-patient-use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly(TM) needleless connector in the US.

In July 2021, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company's Amplifi(TM) Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. A novel vein dilation system aims to improve vascular access for hemodialysis patients.

Key Takeaways from the Vascular Access Device Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies are dominating the global vascular access device market.

Various opportunities are available for the other competitor in the vascular access devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular access devices market growth in the coming future?

Target audience who can be benefited from this Vascular Access Device Market Key Report Study

Vascular access devices providers

Research organizations and consulting companies

Vascular Access Devices related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in vascular access devices

Various end-users want to know more about the vascular access devices market and the latest technological developments in the vascular access devices market

Frequently Asked Questions for Vascular Access Device Market:

What are Vascular Access Device?

Vascular access device are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

What is the market for global vascular access device?

The global vascular access devices market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030.

What are the drivers for global vascular access device?

The major drivers driving the demand for vascular access devices are the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like a rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients, technological advancements in product portfolio coupled with the rising number of product launches and approvals are going to assist in the growth of the vascular access devices market.

What are the key players operating in global vascular access devices?

Some of the key market players operating in the vascular access devices market include Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

What regions have the highest share in the vascular access devices market?

North America is expected to dominate the overall vascular access devices market during the forecast period, 2024 to 2030. This domination is due to the increasing number of patients with chronic and infectious diseases in the region, the presence of key players, the surge in product development activities, proper reimbursement, and others.

Table of Contents

1. Vascular Access Devices Market Report Introduction

2. Vascular Access Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Vascular Access Devices Market Key factors analysis

• 4.1. Vascular Access Devices Market Drivers
  • 4.1.1. Growing prevalence of chronic diseases
  • 4.1.2. Rise in the number of chemotherapies
  • 4.1.3. Rising occurrence of lifestyle diseases in pediatric patients
• 4.2. Vascular Access Devices Market Restraints and Challenges
  • 4.2.1. Incorrect placement of these devices
  • 4.2.2. High cost of these devices
• 4.3. Vascular Access Devices Market Opportunities
  • 4.3.1. Growing preference for adequate delivery of fluids in kidney disease patients
  • 4.3.2. Growing availability of devices coated with bioactive materials

5. Vascular Access Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Vascular Access Devices Market layout

• 6.1. By Device Type
  • 6.1.1. Central Vascular Access Devices
    • 6.1.1.1. Peripherally Inserted Central Catheters (PICC)
    • 6.1.1.2. Non-Tunneled Catheters
    • 6.1.1.3. Others
  • 6.2.1. Peripheral Vascular Access Devices
    • 6.2.1.1. Peripheral Catheter
    • 6.2.1.2. Midline Catheter (Short) Devices
    • 6.2.1.3. Others
• 6.2. By Route of Insertion
  • 6.2.1. Intravenous
  • 6.2.2. Subcutaneous
• 6.3. By End-User
  • 6.3.1. Hospitals
  • 6.3.2. Ambulatory Surgical Centres
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North America Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.1.1. United States Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.1.2. Canada Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.1.3. Mexico Vascular Access Devices Market in USD million (2021-2030)
  • 6.4.2. Europe Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.1. France Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.2. Germany Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.4. Italy Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.5. Spain Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Vascular Access Devices Market in USD million (2021-2030)
  • 6.4.3. Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.1. China Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.2. Japan Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.3. India Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.4. Australia Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.5. South Korea Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3.6. Rest of Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW) Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.4.1. Middle East Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.4.2. Africa Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.4.3. South America Vascular Access Devices Market in USD million (2021-2030)

7. Vascular Access Devices Company and Product Profiles

• 7.1. Cook Medical Inc.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Becton, Dickinson, and Company
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Teleflex Incorporated
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Medtronic PLC
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. B Braun Melsungen AG
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Nipro Medical Corporation
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Smiths Group PLC
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. C. R. Bard, Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Edwards Lifesciences Corporation
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. AngioDynamics
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Terumo Medical Corporation
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Amecath Medical Technologies
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Prodimed
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. B Braun Melsungen AG
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Zoll Medical Corporation
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us